Status:
SUSPENDED
Aortic Valve Regurgitation Acquired After Left Ventricular Assist Device Implantation: an Outstanding in Vivo Model of Valvular Heart Diseases
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Aortic Valve Regurgitation Acquired
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To investigate histological structure and molecular changes involved on the onset of AVD after left ventricular assist device (LVAD) implantation and to compare them with those of patients operated on...
Eligibility Criteria
Inclusion
- Patients with long-term left-ventricular assistance awaiting transplant
- Patients with severe aortic surgical spring deficiency
- Major Patient
Exclusion
- Minor Patient
- Pregnant or nursing women
- Major under guardianship
- People in emergencies
- Persons not covered by the social security scheme
Key Trial Info
Start Date :
September 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 8 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03279029
Start Date
September 14 2017
End Date
August 8 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13354